Related Experiment Video
Updated: Jul 16, 2026
09:48
Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance
Published on: February 17, 2023
The path to insulin resistance: paved with ceramides?
1Department of Molecular Medicine and Surgery, Section of Integrative Physiology, Karolinska Institutet, von Eulers väg 4, S-171 77 Stockholm, Sweden. juleen.zierath@ki.se
Cell Metabolism
|March 7, 2007
Summary
Elevated free fatty acids and inflammatory factors in obesity cause insulin resistance. Research shows that ceramide is a key lipid metabolite driving this insulin resistance, offering a new therapeutic target.
Area of Science:
- Metabolic disease research
- Cellular lipid metabolism
- Insulin signaling pathways
Background:
- Obesity leads to systemic increases in free fatty acids, tumor necrosis factor alpha, and glucocorticoids.
- These factors contribute to elevated intracellular lipid metabolites and promote insulin resistance.
Discussion:
- Holland et al. (2007) investigated the role of ceramide in obesity-induced insulin resistance.
- The study utilized pharmacological and genetic approaches to elucidate ceramide's function.
Key Insights:
- Ceramide, a specific lipid metabolite, is identified as a crucial mediator of insulin resistance.
- Evidence supports ceramide's central role in the development of insulin resistance linked to obesity-associated factors.
Outlook:
- Targeting ceramide metabolism may offer a novel therapeutic strategy for combating insulin resistance.
- Further research into ceramide's precise mechanisms could reveal new avenues for metabolic disease treatment.
Related Concept Videos
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:28Insulin: The Receptor and Signaling Pathways
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
01:38Inflammation
Overview
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:29Cholesterol: Significance and Regulation
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...